HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

XIO Group Buys Laser Manufacturer Lumenis

By HospiMedica International staff writers
Posted on 01 Jul 2015
Print article
Lumenis (Yokneam, Israel) has signed a definitive agreement to be acquired by XIO Group (Hong Kong, China) for approximately USD 510 million.

Lumenis is currently the world's largest energy-based medical device manufacturer of surgical, ophthalmology, and aesthetic applications, provides devices that use energy-based technologies including laser, intense pulsed light (IPL), and radio-frequency (RF) technologies. The company has an active installed worldwide base of more than 80,000 systems, and a commercial presence in over 100 countries.

The XIO investment fund, with executive offices Hong Kong and offices in London and Shanghai, made the offer a little over a year since the medical company went public on NASDAQ, after a ten year hiatus since being delisted in 2005. The boards of directors of both companies have approved the transaction, which is expected to close in September 2015.The largest shareholders of Lumenis, Viola Group and XT Hi-Tech Investments (which collectively own approximately 59% of the shares), have entered into a customary voting agreement with XIO Group.

“Over the past three years we have managed to transform Lumenis into a strong, growing, and profitable company. We have refocused our strategy, introduced new products, and tripled our EBITDA,” said Tzipi Ozer-Armon, CEO of Lumenis. “Furthermore, we have created a very bright and promising future for Lumenis by building a robust pipeline of innovative products, a strong sales team in each region, and by enhancing our global brand recognition.”

“We are excited about the announced transaction and the value created for Lumenis' shareholders,” said Harel Beit-On, chairman of the board of directors of Lumenis. “Over the last years, we had an opportunity to lead Lumenis through a strategic transformation into a valuable growing business with global appeal. We respect and appreciate the efforts of Lumenis management and employees and wish the company continued success.”

Chinese companies have made recent large investments in Israeli companies in both high-tech and other industries. The most prominent transaction was the acquisition of Tnuva, Israel's largest dairy company, by Bright Food, and some 30 Chinese investors have invested in about 80 startups.

Related Links:

Lumenis
XIO Group


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Illuminated Retractor System
HandLite

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more